VYOME HOLDINGS INC (HIND)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.22-0.45%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · HIND
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 0.1 | 0.3 | 8.0 | 8.7 | 11.2 | 13.6 | 11.3 | 3.3 | 9.1 | 9.9 | 3.4 |
| Total Revenues | 0.1 | 0.3 | — | — | — | — | — | — | 9.1 | 9.9 | 3.4 |
| Cost of Revenues | 0.1 | 0.1 | 2.9 | 3.1 | 4.4 | 5.3 | 5.0 | 3.0 | 5.4 | 4.8 | 2.8 |
| Gross Profit | 0.1 | 0.2 | 5.1 | 5.5 | 6.8 | 8.3 | 6.3 | 0.3 | 3.7 | 5.1 | 0.6 |
| Operating Expenses & Income | |||||||||||
| Selling, General & Admin | 2.7 | 2.4 | — | 7.5 | 14.1 | 8.9 | 4.7 | 16.7 | 29.9 | 28.8 | 10.2 |
| R&D Expenses | 1.6 | 0.6 | 1.8 | 2.3 | 2.5 | 2.4 | 3.5 | 6.9 | 10.7 | 10.6 | 9.9 |
| Operating Income | (11.9) | (10.5) | (7.7) | (15.4) | (46.4) | (57.9) | (12.5) | (23.2) | (37.0) | (34.4) | (19.5) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | 0.1 | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 0.3 | (0.0) | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | — | — | 0.8 | — | 28.8 | 1.3 | — | — | — | — |
| EBT, Incl. Unusual Items | — | — | (7.1) | (11.3) | (46.6) | (63.4) | (21.8) | — | — | — | — |
| Income Tax Expense | — | — | 0.0 | 0.1 | (0.4) | (0.3) | (0.2) | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||||
| Minority Interest | — | (0.2) | — | — | — | — | — | — | — | — | — |
| Net Income | (11.3) | (10.3) | (7.1) | (11.4) | (46.2) | (63.1) | (21.6) | (23.7) | (37.4) | (34.8) | (20.5) |
| Per Share | |||||||||||
| Basic EPS | (1.61) | (4.86) | (13.83) | (110.87) | (108.90) | (288.97) | (5.55) | — | — | — | — |
| Diluted EPS | — | (4.86) | (13.83) | (110.87) | (108.90) | (288.97) | (5.55) | — | — | — | — |
| Basic Weighted Avg Shares | 7.0 | 2.2 | 0.5 | 0.1 | 0.4 | 0.2 | 3.9 | — | — | — | — |
| Diluted Weighted Avg Shares | — | 2.2 | 0.5 | 0.1 | 0.4 | 0.2 | 3.9 | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | (10.4) | — | — | — | — | (12.1) | — | — | (34.1) | (19.3) |
| EBIT | (11.9) | (10.5) | (7.7) | (15.4) | (46.4) | (57.9) | (12.5) | (23.2) | (37.0) | (34.4) | (19.5) |
| Effective Tax Rate | — | — | — | -0.5% | 0.8% | 0.4% | 0.8% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.